Profil
Shutsung Liao is a Professor at The University of Chicago and a Member of both the National Academy of Sciences and the American Academy of Arts & Sciences.
He was formerly the Chairman & CEO of Anagen Therapeutics, Inc. and a Scientific Advisor at ARCH Venture Partners LLC.
Postes actifs de Shutsung Liao
| Sociétés | Poste | Début |
|---|---|---|
The University of Chicago
The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
National Academy of Sciences
National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a private, nongovernmental institution that advises on issues related to science and technology | Corporate Officer/Principal | - |
American Academy of Arts & Sciences
American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services Operates as organization which honours excellence and convenes leaders | Corporate Officer/Principal | - |
Anciens postes connus de Shutsung Liao
| Sociétés | Poste | Fin |
|---|---|---|
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Corporate Officer/Principal | 01/12/2007 |
Anagen Therapeutics, Inc.
Anagen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures health care products | Directeur Général | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Finance |
The University of Chicago
The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anagen Therapeutics, Inc.
Anagen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures health care products | Health Technology |
National Academy of Sciences
National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a private, nongovernmental institution that advises on issues related to science and technology | Commercial Services |
American Academy of Arts & Sciences
American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services Operates as organization which honours excellence and convenes leaders | Commercial Services |
















